Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriol Bestard

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Journal of Nephrology|June 2, 2016
Monitoring alloimmune response in kidney transplantationOriol Bestard, Paolo Cravedi
Clinical Biochemistry|August 18, 2015
Biomarkers to assess donor-reactive T-cell responses in kidney transplant patientsElena Crespo, Oriol Bestard
Pediatric Nephrology (Berlin, Germany)|December 16, 2014
Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppressionOriol Bestard, Minnie M Sarwal
Transplant International : Official Journal of the European Society for Organ Transplantation|August 5, 2017
Refinement of humoral immune monitoring in kidney transplantation: the role of "hidden" alloreactive memory B cellsSergi Luque, Marc Lúcia, Oriol Bestard
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
Immunosuppressive drugs modes of actionMaria Meneghini, Oriol Bestard, Josep Maria Grinyo
Transplantation|August 12, 2009
New immunosuppressive protocols with the advent of novel biological drugsJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Contributions to Nephrology|November 13, 2008
Control of anti-donor antibody production post-transplantation: conventional and novel immunosuppressive therapiesJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Contributions to Nephrology|February 8, 2012
Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantationJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Transplantation|April 23, 2009
Inhibitors of the mammalian target of rapamycin and transplant toleranceOriol Bestard, Josep M Cruzado, Josep M Grinyó
Drugs|April 7, 2006
Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability?Oriol Bestard, Josep M Cruzado, Josep M Grinyó
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Journal of Nephrology|June 2, 2016
Monitoring alloimmune response in kidney transplantationOriol Bestard, Paolo Cravedi
Clinical Biochemistry|August 18, 2015
Biomarkers to assess donor-reactive T-cell responses in kidney transplant patientsElena Crespo, Oriol Bestard
Pediatric Nephrology (Berlin, Germany)|December 16, 2014
Antibody-mediated rejection in young kidney transplant recipients: the dilemma of noncompliance and insufficient immunosuppressionOriol Bestard, Minnie M Sarwal
Transplant International : Official Journal of the European Society for Organ Transplantation|August 5, 2017
Refinement of humoral immune monitoring in kidney transplantation: the role of "hidden" alloreactive memory B cellsSergi Luque, Marc Lúcia, Oriol Bestard
Best Practice & Research. Clinical Gastroenterology|December 7, 2021
Immunosuppressive drugs modes of actionMaria Meneghini, Oriol Bestard, Josep Maria Grinyo
Transplantation|August 12, 2009
New immunosuppressive protocols with the advent of novel biological drugsJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Contributions to Nephrology|November 13, 2008
Control of anti-donor antibody production post-transplantation: conventional and novel immunosuppressive therapiesJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Contributions to Nephrology|February 8, 2012
Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantationJosep M Cruzado, Oriol Bestard, Josep M Grinyó
Transplantation|April 23, 2009
Inhibitors of the mammalian target of rapamycin and transplant toleranceOriol Bestard, Josep M Cruzado, Josep M Grinyó
Drugs|April 7, 2006
Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability?Oriol Bestard, Josep M Cruzado, Josep M Grinyó
Pageof 18